In conclusion, it elucidated the critical role of cytosolic mtDNA-induced cGAS-STING activation in the pathogenesis of obesity-related DCM and provided preclinical validation as a new potential therapeutic strategy for the treatment of DCM. Here, STING1 is linked to obesity disorder.